Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial (a Substudy of the TRIGS Trial)

NCT05470816 is registered in ClinicalTrials.gov with Bayside Health as lead sponsor.

NCT NCT05470816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05470816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial (a Substudy of the TRIGS Trial)
Lead sponsor
Bayside Health
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 1, 2022
Completion date
August 31, 2026
Enrollment
826 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognition, dementia, surgical site infection